Log In
Print
BCIQ
Print
Print this Print this
 

PSMA ADC

Also known as: Prostate vaccine

  Manage Alerts
Collapse Summary General Information
Company Progenics Pharmaceuticals Inc.
DescriptionAntibody-drug conjugate (ADC) composed of a human mAb against prostate-specific membrane antigen (PSMA; FOLH1; GCPII) and monomethyl auristatin E (MMAE)
Molecular Target Prostate-specific membrane antigen (PSMA) (FOLH1) (GCPII)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPhase II
Standard IndicationProstate cancer
Indication DetailsTreat metastatic castration-resistant prostate cancer (CRPC)
Regulatory Designation

Partner

Seattle Genetics Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today